Eli Lilly: 1 Big Reason for UK Gateway Lab Reconsideration
Reports suggest pharmaceutical giant Eli Lilly is reconsidering its major UK Gateway Lab investment. Learn why the company’s future plans in Britain are now uncertain.
Reports suggest pharmaceutical giant Eli Lilly is reconsidering its major UK Gateway Lab investment. Learn why the company’s future plans in Britain are now uncertain.
A significant leadership restructuring at Intel sees the departure of its chief executive of products. This move is part of a wider 2024 strategy shift.
An exclusive look at the new ceo set to steer Parfums de Marly and Initio Parfums Privés. Learn about the future direction for these luxury fragrance brands.